[go: up one dir, main page]

ES527289A0 - Un metodo para preparar una mezcla liofilizada de polvo absorbible y acido aminocaproico - Google Patents

Un metodo para preparar una mezcla liofilizada de polvo absorbible y acido aminocaproico

Info

Publication number
ES527289A0
ES527289A0 ES527289A ES527289A ES527289A0 ES 527289 A0 ES527289 A0 ES 527289A0 ES 527289 A ES527289 A ES 527289A ES 527289 A ES527289 A ES 527289A ES 527289 A0 ES527289 A0 ES 527289A0
Authority
ES
Spain
Prior art keywords
aminocaproic acid
preparing
lyophilized mixture
absorbable
absorbable powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES527289A
Other languages
English (en)
Other versions
ES8600733A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Serono Pharmaceutical Partners
Original Assignee
Serono Pharmaceutical Partners
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Pharmaceutical Partners filed Critical Serono Pharmaceutical Partners
Publication of ES527289A0 publication Critical patent/ES527289A0/es
Publication of ES8600733A1 publication Critical patent/ES8600733A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES527289A 1982-11-16 1983-11-15 Un metodo para preparar una mezcla liofilizada de polvo absorbible y acido aminocaproico Expired ES8600733A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/442,151 US4540410A (en) 1982-11-16 1982-11-16 Lyophilized compositions, preparation and use thereof

Publications (2)

Publication Number Publication Date
ES527289A0 true ES527289A0 (es) 1985-11-01
ES8600733A1 ES8600733A1 (es) 1985-11-01

Family

ID=23755732

Family Applications (2)

Application Number Title Priority Date Filing Date
ES527289A Expired ES8600733A1 (es) 1982-11-16 1983-11-15 Un metodo para preparar una mezcla liofilizada de polvo absorbible y acido aminocaproico
ES546583A Expired ES8706312A1 (es) 1982-11-16 1985-08-30 Un metodo para preparar un compuesto para curar cicatrices cutaneas hundidas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES546583A Expired ES8706312A1 (es) 1982-11-16 1985-08-30 Un metodo para preparar un compuesto para curar cicatrices cutaneas hundidas.

Country Status (12)

Country Link
US (1) US4540410A (es)
EP (1) EP0109188B1 (es)
AT (1) ATE24838T1 (es)
AU (1) AU558164B2 (es)
CA (1) CA1228542A (es)
DE (1) DE3369070D1 (es)
DK (1) DK164538C (es)
ES (2) ES8600733A1 (es)
IL (1) IL69923A (es)
NO (1) NO165625C (es)
PT (1) PT77621B (es)
ZA (1) ZA837407B (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6144825A (ja) * 1984-08-09 1986-03-04 Unitika Ltd 止血剤
JPS6150912A (ja) * 1984-08-16 1986-03-13 Shionogi & Co Ltd リポソ−ム製剤の製造法
US4743229A (en) * 1986-09-29 1988-05-10 Collagen Corporation Collagen/mineral mixing device and method
DE3816961A1 (de) * 1987-07-21 1989-02-02 Wasserburger Arzneimittelwerk Injektionsspritze fuer medizinische zwecke
EP0365704A1 (de) * 1988-10-26 1990-05-02 Zentralna Problemna Laboratoria Po Kryobiologia I Lyophilisazia Biopräparat für Hämostase bei Magenblutungen
US5063178A (en) * 1990-03-19 1991-11-05 Medex, Inc. Freeze-dried blood gas sensor
FR2694496A1 (fr) * 1992-08-05 1994-02-11 Bernstein Serge Procédé pour l'obtention d'un produit permettant l'expansion des seins et le traitement des rides.
US6066325A (en) * 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US7435425B2 (en) * 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US7871637B2 (en) * 1996-08-27 2011-01-18 Baxter International Inc. Dry hemostatic compositions and methods for their preparation
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US6527738B1 (en) * 1999-04-30 2003-03-04 Prismedical Corporation Drug delivery pack
US20010037091A1 (en) * 1999-12-29 2001-11-01 Wironen John F. System for reconstituting pastes and methods of using same
US8834864B2 (en) * 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US7927626B2 (en) * 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
US7101354B2 (en) 2004-05-03 2006-09-05 Infusive Technologies, Llc Mixing syringe with and without flush
US7998106B2 (en) 2004-05-03 2011-08-16 Thorne Jr Gale H Safety dispensing system for hazardous substances
WO2007137839A2 (en) * 2006-05-31 2007-12-06 Baxter International Inc. Method for directed cell in-growth and controlled tissue regeneration in spinal surgery
EP1870649A1 (en) * 2006-06-20 2007-12-26 Octapharma AG Lyophilisation targetting defined residual moisture by limited desorption energy levels
TWI436793B (zh) 2006-08-02 2014-05-11 巴克斯特國際公司 快速作用之乾密封膠及其使用和製造方法
AU2008317874B2 (en) 2007-10-30 2013-12-19 Baxter Healthcare S.A. Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects
WO2009109194A2 (en) 2008-02-29 2009-09-11 Ferrosan A/S Device for promotion of hemostasis and/or wound healing
US9039783B2 (en) 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
WO2010145817A2 (en) * 2009-06-16 2010-12-23 Baxter International Inc. Hemostatic sponge
BR112012014773A2 (pt) 2009-12-16 2015-11-03 Baxter Healthcare Sa esponja de compósito hemostática, método para fabricar uma esponja de compósito hemostática, e, uso da referida esponja
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
ES2682302T3 (es) * 2010-06-01 2018-09-19 Baxter International Inc Proceso para la producción de composiciones hemostáticas secas y estables
WO2011151384A1 (en) 2010-06-01 2011-12-08 Baxter International Inc. Process for making dry and stable hemostatic compositions
BR112012030463B1 (pt) * 2010-06-01 2021-08-24 Baxter International Inc. Processo para fabricar uma composição hemostática seca e estável, recipiente acabado final, kit para administrar uma composição hemostática, e, grânulos revestidos com trombina
ES2938566T3 (es) 2011-10-11 2023-04-12 Baxter Int Composiciones hemostaticas
JP6195569B2 (ja) 2011-10-11 2017-09-13 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 止血組成物
SG11201401878SA (en) 2011-10-27 2014-09-26 Baxter Int Hemostatic compositions
CN104159527B (zh) 2012-03-06 2017-04-12 弗罗桑医疗设备公司 包含止血糊剂的压力容器
BR112014030962A2 (pt) 2012-06-12 2017-06-27 Ferrosan Medical Devices As métodos para preparação e para reconstituição de uma composição seca adequada para uso em hemostase e cicatrização de feridas, e, kit hemostático
WO2014202760A2 (en) 2013-06-21 2014-12-24 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
BR112016013322B1 (pt) 2013-12-11 2020-07-21 Ferrosan Medical Devices A/S métodos para preparação de uma composição seca e para reconstituir uma composição seca, composição seca, uso de uma composição seca, e, kit
BR112017007466B1 (pt) 2014-10-13 2021-03-02 Ferrosan Medical Devices A/S método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca
EP3237041B1 (en) 2014-12-24 2020-01-29 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
WO2017005590A1 (en) 2015-07-03 2017-01-12 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
AU2019266529B2 (en) 2018-05-09 2024-05-23 Ethicon Inc. Method for preparing a haemostatic composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB450145A (en) * 1934-01-13 1936-07-06 Sharp & Dohme Inc Lyophilic biologically active substances and process of producing the same
GB455027A (en) * 1935-01-04 1935-08-01 Sharp & Dohme Inc Normal serum product and process of producing the same
US2380339A (en) * 1941-07-10 1945-07-10 Fromm Lab Inc Method and apparatus for preserving biological substances
US3743714A (en) * 1970-12-04 1973-07-03 Cis Radiopharmaceuticals Inc Novel carrier preparations for injectable radioactive compositions
US4006220A (en) * 1975-06-04 1977-02-01 Gottlieb Sheldon K Compositions and methods useful for repairing depressed cutaneous scars
US4191751A (en) * 1975-06-04 1980-03-04 Gottlieb Sheldon K Method for promoting growth of new connective tissue over surface wounds
US4167945A (en) * 1977-01-31 1979-09-18 Gottlieb Sheldon K Method for enhancing the healing of grafted tissue

Also Published As

Publication number Publication date
NO165625C (no) 1991-03-13
ES8706312A1 (es) 1987-07-01
NO165625B (no) 1990-12-03
PT77621B (en) 1986-03-19
ES8600733A1 (es) 1985-11-01
ZA837407B (en) 1985-05-29
DK521283D0 (da) 1983-11-15
DK521283A (da) 1984-05-17
DK164538B (da) 1992-07-13
IL69923A (en) 1987-03-31
AU558164B2 (en) 1987-01-22
CA1228542A (en) 1987-10-27
EP0109188B1 (en) 1987-01-14
NO834183L (no) 1984-05-18
US4540410A (en) 1985-09-10
AU2091683A (en) 1984-05-24
DE3369070D1 (en) 1987-02-19
DK164538C (da) 1993-01-11
EP0109188A1 (en) 1984-05-23
ATE24838T1 (de) 1987-01-15
PT77621A (en) 1983-12-01
ES546583A0 (es) 1987-07-01

Similar Documents

Publication Publication Date Title
ES527289A0 (es) Un metodo para preparar una mezcla liofilizada de polvo absorbible y acido aminocaproico
DK528483D0 (da) Flyveaske i lageregnet form og fremgangsmade til fremstilling af samme
JPS52150717A (en) Separation of yttrium
JPS5224200A (en) Method for production of spherical ferrite powder
JPS5278828A (en) Preparation of high concentration olefin sulfonate solution
JPS5523110A (en) Grout and grouting method
JPS5271433A (en) Preparation of aromatic polycarboxylic acid arylester
JPS5231125A (en) Metal fibers and their preparation
JPS51149575A (en) Preparation method of a power cable
JPS53400A (en) Washing method for mixing stirrer of radioactive waste and cement
JPS5224879A (en) Mixed feed for land produced shellfish
JPS51137294A (en) High anchoring power unit
JPS51128420A (en) A method for preparing a pharmaceutical containing enzymes
JPS5228705A (en) Concrete press feeding pump
JPS528583A (en) Device and method for continuous cutting and injection of glass fiber
JPS5329297A (en) Production of gypsum long fibers
JPS53101593A (en) Preparation of antibiotics marthiomycin
JPS56129290A (en) Modification of ground
JPS523896A (en) Method of preparing yeast proteins capable of gel formation
JPS5247483A (en) Method for producing active feed by the use of various lees of brewage and fruits
SU1225215A1 (ru) Способ приготовления бетонной смеси
JPS51120973A (en) Method of solidiying sluge for disposal
JPS5785884A (en) Hardener for water glass
CA991809A (en) Method and mixture for producing an artificial skiing track
JPS5537476A (en) Producing sawdust mixed cement mortar

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519